1. Home
  2. AUPH vs CWH Comparison

AUPH vs CWH Comparison

Compare AUPH & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • CWH
  • Stock Information
  • Founded
  • AUPH 1993
  • CWH 1966
  • Country
  • AUPH Canada
  • CWH United States
  • Employees
  • AUPH N/A
  • CWH N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • CWH Retail-Auto Dealers and Gas Stations
  • Sector
  • AUPH Health Care
  • CWH Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • CWH Nasdaq
  • Market Cap
  • AUPH 1.6B
  • CWH 1.1B
  • IPO Year
  • AUPH 1999
  • CWH 2016
  • Fundamental
  • Price
  • AUPH $13.17
  • CWH $13.16
  • Analyst Decision
  • AUPH Strong Buy
  • CWH Strong Buy
  • Analyst Count
  • AUPH 2
  • CWH 9
  • Target Price
  • AUPH $13.00
  • CWH $19.00
  • AVG Volume (30 Days)
  • AUPH 1.2M
  • CWH 2.3M
  • Earning Date
  • AUPH 11-07-2025
  • CWH 10-28-2025
  • Dividend Yield
  • AUPH N/A
  • CWH 4.02%
  • EPS Growth
  • AUPH N/A
  • CWH N/A
  • EPS
  • AUPH 0.42
  • CWH N/A
  • Revenue
  • AUPH $260,111,000.00
  • CWH $6,400,054,000.00
  • Revenue This Year
  • AUPH $17.33
  • CWH $4.97
  • Revenue Next Year
  • AUPH $14.31
  • CWH $6.87
  • P/E Ratio
  • AUPH $31.33
  • CWH N/A
  • Revenue Growth
  • AUPH 25.59
  • CWH 6.58
  • 52 Week Low
  • AUPH $6.55
  • CWH $11.17
  • 52 Week High
  • AUPH $13.54
  • CWH $25.97
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 65.73
  • CWH 35.05
  • Support Level
  • AUPH $11.96
  • CWH $11.98
  • Resistance Level
  • AUPH $12.70
  • CWH $17.15
  • Average True Range (ATR)
  • AUPH 0.44
  • CWH 0.86
  • MACD
  • AUPH 0.15
  • CWH -0.26
  • Stochastic Oscillator
  • AUPH 94.35
  • CWH 22.82

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

Share on Social Networks: